618.57

0.68% 4.15

After Hours: 618.57

Thermo Fisher Scientific Inc (TMO)

Overview News Price History Option Chain Financials Why TMO Down? Discussions Forecast Stock Split Dividend History

Thermo Fisher Scientific Inc stock is traded at $618.57, with a volume of 991.55K. It is up +0.68% in the last 24 hours and up +0.57% over the past month. Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of end-2023 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (10%); life science solutions (23%); and lab products and services, which includes CRO services (54%).

Previous Close:

$614.42

Open:

$612.49

24h Volume:

991.55K

Relative Volume:

0.72

Market Cap:

$234.34B

Revenue:

$42.35B

Net Income/Loss:

$6.22B

P/E Ratio:

40.54

EPS:

15.26

Net Cash Flow:

$7.96B

1W Performance:

+1.35%

1M Performance:

+0.57%

6M Performance:

+6.43%

1Y Performance:

+22.21%

1-Day Range:

$609.03

$619.02

1-Week Range:

$596.00

$623.76

52-Week Range:

$415.60

$627.88

Thermo Fisher Scientific Inc Stock (TMO) Company Profile

Name

Thermo Fisher Scientific Inc

Sector

Healthcare (1203)

Industry

Diagnostics & Research (58)

Phone

(781) 622-1000

Address

168 THIRD AVENUE, WALTHAM, MA

Employee

122,000

Twitter

@thermofisher

Next Earnings Date

2024-10-23

Latest SEC Filings

TMO's Discussions on Twitter

Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-03-24	Resumed	Jefferies	Buy
Mar-18-24	Resumed	Citigroup	Neutral
Jan-24-24	Downgrade	Barclays	Overweight → Equal Weight
Jan-08-24	Downgrade	Bernstein	Outperform → Mkt Perform
Dec-18-23	Initiated	HSBC Securities	Buy
Dec-13-23	Initiated	Wolfe Research	Outperform
Oct-26-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Oct-25-23	Upgrade	Wells Fargo	Underweight → Equal Weight
Sep-28-23	Initiated	Bernstein	Outperform
Sep-06-23	Resumed	Citigroup	Buy
Jul-19-23	Initiated	Raymond James	Outperform
Jul-19-23	Reiterated	Robert W. Baird	Outperform
Jul-13-23	Upgrade	Credit Suisse	Neutral → Outperform
Apr-04-23	Reiterated	Barclays	Overweight
Dec-14-22	Initiated	Deutsche Bank	Buy
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Oct-27-22	Downgrade	The Benchmark Company	Buy → Hold
Aug-25-22	Initiated	Credit Suisse	Neutral
Apr-25-22	Downgrade	Wells Fargo	Equal Weight → Underweight
Jan-26-22	Resumed	Barclays	Overweight
Oct-20-21	Upgrade	Citigroup	Neutral → Buy
Oct-15-21	Resumed	Cowen	Outperform
Aug-05-21	Resumed	Credit Suisse	Outperform
Jul-16-21	Initiated	The Benchmark Company	Buy
Mar-18-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-03-21	Initiated	Barclays	Overweight
Jan-08-21	Upgrade	Credit Suisse	Neutral → Outperform
Dec-16-20	Downgrade	Citigroup	Buy → Neutral
Dec-02-20	Initiated	Goldman	Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-30-20	Initiated	Atlantic Equities	Overweight
Sep-14-20	Initiated	Morgan Stanley	Overweight
Aug-20-20	Resumed	JP Morgan	Overweight
Jul-15-20	Upgrade	Cleveland Research	Neutral → Buy
Jul-07-20	Reiterated	Needham	Buy
Apr-23-20	Reiterated	Needham	Buy
Jan-31-20	Reiterated	Needham	Buy
Jan-22-20	Initiated	Credit Suisse	Neutral
Jan-08-20	Initiated	Wells Fargo	Equal Weight
Jan-07-20	Initiated	Citigroup	Buy
Nov-15-19	Initiated	Stifel	Buy
Jul-25-19	Reiterated	Needham	Buy
Jul-16-19	Downgrade	Needham	Strong Buy → Buy
May-30-19	Initiated	Wolfe Research	Outperform
May-23-19	Reiterated	Needham	Strong Buy
Apr-22-19	Reiterated	Needham	Strong Buy
Apr-16-19	Reiterated	BofA/Merrill	Buy

View All

Thermo Fisher Scientific Inc Stock (TMO) Latest News

08:15 AM

Thermo Fisher Scientific Launches International CorEvitas Clinical Registry in Adolescent Atopic Dermatitis, a Chronic Skin Condition - Business Wire

08:15 AM

05:56 AM

Senator Investment Group LP Sells 5,000 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat

05:56 AM

04:53 AM